AI assistant
Sending…
Personalis, Inc. — Director's Dealing 2023
Nov 20, 2023
32721_dirs_2023-11-20_a905638c-02b5-4a63-9195-322980abd7bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Personalis, Inc. (PSNL)
CIK: 0001527753
Period of Report: 2023-11-16
Reporting Person: Chen Richard (Chief Medical Officer and EVP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-16 | Common Stock | S | 940 | $1.04 | Disposed | 124104 | Direct |
Footnotes
F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
More from Personalis, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26